Hindalco Industries Ltd vs Sudarshan Pharma Industries Ltd

A side-by-side comparison of Hindalco Industries Ltd (HINDALCO) and Sudarshan Pharma Industries Ltd (SUDARSHAN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Hindalco Industries Ltd leads HINDALCO vs SUDARSHAN on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

15.97
P/E ratio
64.11
1.56
P/B ratio
6.37
0.52%
Dividend yield
0.73%
₹59.59
EPS
₹0.66

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

13.50%
Return on equity
12.13%
14.00%
Return on capital
16.00%
13.00%
EBITDA margin
8.00%
4.87%
Net margin
3.17%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.20%
Revenue CAGR (3Y)
15.11%
9.87%
Profit CAGR (3Y)
49.14%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.13L Cr
Market cap
₹988 Cr
₹2.75L Cr
Revenue
₹505 Cr
₹13,391 Cr
Net profit
₹16 Cr
0.73
Debt / equity
1.84
Hindalco Industries Ltd
  • + ["Company has delivered good profit growth of 35.2% CAGR over last 5 years"]
  • ["Company has a low return on equity of 12.5% over last 3 years.", "Company might be capitalizing the interest cost"]
Sudarshan Pharma Industries Ltd
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 54.2% CAGR over last 5 years", "Company's working capital requirements have reduced from 44.1 days to 17.1 days"]
  • ["Stock is trading at 6.37 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
Hindalco Industries Ltd full analysis Sudarshan Pharma Industries Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.